Treatment and evaluation of CLL: A complicated affair

Research output: Contribution to journalShort surveypeer-review

1 Scopus citations


In this issue, Eichhorst and colleagues show in a large randomized phase 3 clinical trial that combination therapy using fludarabine and cyclophosphamide is superior to fludarabine alone for younger previously untreated CLL patients. In addition, they found a reduced level of clinical responses when imaging was considered as part of restaging compared with responses defined by recommended NCI standards.

Original languageEnglish (US)
Pages (from-to)848
Number of pages1
Issue number3
StatePublished - Feb 1 2006

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology


Dive into the research topics of 'Treatment and evaluation of CLL: A complicated affair'. Together they form a unique fingerprint.

Cite this